Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rethinking Early Airway Clearence Therapies

NCT07696338 is registered in ClinicalTrials.gov with Nicole Hamblett as lead sponsor.

NCT NCT07696338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rethinking Early Airway Clearence Therapies
Lead sponsor
Nicole Hamblett
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
February 28, 2030
Enrollment
405 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis (cf)